Column Group Ii, Lp Rapt Therapeutics, Inc. (RAPT) insider trading activity

Column Group Ii, LP is of RAPT Therapeutics, Inc.. Currently has a direct ownership of 50,000 shares of RAPT, which is worth approximately $58,500. The most recent transaction as insider was on Dec 23, 2024, when has been sold 1,352,008 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K

96.43% 3M change

96.43% 12M change

Total Value Held $58,500

COLUMN GROUP II, LP Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 23 2024	SELL Other acquisition or disposition	-	1,352,008 Reduced 96.43%	50,000 Common Stock
Dec 23 2024	SELL Other acquisition or disposition	-	1,352,008 Reduced 96.43%	50,000 Common Stock
Sep 10 2021	SELL Other acquisition or disposition	-	1,166,666 Reduced 45.42%	1,402,008 Common Stock
Aug 18 2021	SELL Other acquisition or disposition	-	1,317,005 Reduced 33.89%	2,568,674 Common Stock
Sep 22 2020	SELL Open market or private sale	$18,756,800 $30.85 p/Share	608,000 Reduced 13.68%	3,835,679 Common Stock
Aug 17 2020	SELL Open market or private sale	$12,254,378 $22.75 p/Share	538,654 Reduced 10.81%	4,443,679 Common Stock
Nov 04 2019	BUY Open market or private purchase	$7,500,000 $12.0 p/Share	625,000 Added 11.15%	4,982,333 Common Stock
Nov 04 2019	BUY Conversion of derivative security	-	6,102,151 Added 97.67%	145,401 Common Stock

Also insider at

RCUS

Arcus Biosciences, Inc. Healthcare

> 10% Shareholder

ORIC

Oric Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

CGI